
Intuitive Surgical Faces Valuation Crossroads After Strong Q4 Results
Intuitive Surgical posted strong Q4 results with 19% revenue growth, but 2026 guidance signals meaningful deceleration. At 63x earnings, stock appears fairly valued for current shareholders but overvalued for new investors.
ISRGmedical devicesvaluation risk

